Hepatic Artery Infusion Chemotherapy: A Quality Framework
Ann Surg Oncol
.
2024 Feb;31(2):701-704.
doi: 10.1245/s10434-023-14515-y.
Epub 2023 Nov 14.
Authors
Lauren M Janczewski
1
,
Ryan J Ellis
2
,
Michael E Lidsky
3
,
Michael I D'Angelica
4
,
Ryan P Merkow
5
Affiliations
1
Department of Surgery, Northwestern University Feinberg School of Medicine, University, Chicago, IL, USA.
2
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
3
Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
4
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
5
Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, IL, USA. Ryan.Merkow@bsd.uchicago.edu.
PMID:
37962738
DOI:
10.1245/s10434-023-14515-y
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Fluorouracil / therapeutic use
Hepatic Artery*
Humans
Infusion Pumps, Implantable
Infusions, Intra-Arterial
Liver Neoplasms* / drug therapy
Substances
Fluorouracil
Grants and funding
T32 CA247801/CA/NCI NIH HHS/United States